Related Experiment Video
Updated: Jul 13, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor beta1 gene polymorphism 509C/T in deep infiltrating endometriosis
K J A F van Kaam1, A Romano, G A J Dunselman
1Research Institute GROW, University Hospital of Maastricht, Maastricht, Netherlands. kvk@sgyn.azm.nl
This study investigated the link between a specific gene variation, the TGF-beta 1 -509C/T polymorphism, and deep infiltrating endometriosis. The findings indicate no significant association, suggesting this polymorphism does not increase the risk for endometriosis.
Area of Science:
- Reproductive Medicine
- Genetics
- Oncology
Background:
- Deep infiltrating endometriosis involves fibromuscular nodular lesions.
- Transforming growth factor beta 1 (TGF-beta1) is implicated in fibrotic disorders.
- Gene polymorphisms may influence TGF-beta1 activity and endometriosis risk.
Purpose of the Study:
- To investigate the association between the TGF-beta 1 -509C/T gene polymorphism and deep infiltrating endometriosis.
- To determine if this specific polymorphism increases the risk of developing deep infiltrating endometriosis.
Main Methods:
- Case-control study comparing women with deep infiltrating endometriosis, gynecological patients without endometriosis, and healthy females.
- Genotyping of the TGF-beta 1 -509C/T polymorphism using PCR-restriction fragment length polymorphism analysis.
Main Results:
- No statistically significant differences were observed in the frequency of the TGF-beta 1 -509C/T polymorphism among the study groups.
- The analysis did not reveal a correlation between the -509C/T polymorphism and deep infiltrating endometriosis.
Conclusions:
- The study does not support a link between the TGF-beta 1 -509C/T gene polymorphism and an increased risk of deep infiltrating endometriosis.
- Further research may be needed to explore other genetic factors or biological mechanisms involved in endometriosis pathogenesis.
Related Concept Videos
TGF - β Signaling Pathway
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
